PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.34%
Positive revenue growth while MRVL is negative. John Neff might see a notable competitive edge here.
7.29%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
14.75%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
14.68%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
21.75%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
23.26%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.81%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.04%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.63%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
9.10%
Dividend growth of 9.10% while MRVL is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
20.02%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-7.07%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
54.53%
10Y revenue/share CAGR under 50% of MRVL's 387.08%. Michael Burry would suspect a lasting competitive disadvantage.
32.29%
5Y revenue/share CAGR under 50% of MRVL's 74.22%. Michael Burry would suspect a significant competitive gap or product weakness.
2.56%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
42.74%
10Y OCF/share CAGR under 50% of MRVL's 2005.39%. Michael Burry would worry about a persistent underperformance in cash creation.
6.47%
Below 50% of MRVL's 123.38%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
40.02%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
99.29%
Net income/share CAGR 1.25-1.5x MRVL's 88.19%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
85.55%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
15.90%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
45.75%
Positive growth while MRVL is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
3.31%
Below 50% of MRVL's 44.45%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.15%
Below 50% of MRVL's 16.85%. Michael Burry suspects a serious short-term disadvantage in building book value.
508.03%
Dividend/share CAGR of 508.03% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
370.06%
Dividend/share CAGR of 370.06% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
203.64%
3Y dividend/share CAGR of 203.64% while MRVL is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.01%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
7.71%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.81%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.09%
BV/share growth above 1.5x MRVL's 0.47%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-3.80%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
2.35%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.